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The G1/S transition is a crucial decision point in the cell cycle. At G1/S, there is an abrupt
switch from a state of high cyclin-dependent kinases (CDK) inhibitor (CKI) levels and
low S-phase CDK activity to a state of high S-phase CDK activity and degraded CKI.
In budding yeast, this transition is triggered by phosphorylation of the Cdk1 inhibitor
Sic1 at multiple sites by G1-phase CDK (Cln1,2-Cdk1) and S-phase CDK (Clb5,6-Cdk1)
complexes. Using mathematical modeling we demonstrate that the mechanistic basis
for the abruptness of the G1/S transition is the highly specific phosphorylation of Sic1
by S-phase CDK complex. This switch is generated by a double-negative feedback loop in
which S-CDK1 phosphorylates Sic1, thus targeting it for destruction, and thereby liberating
further S-CDK1 from the inhibitory Sic1-S-CDK1 complex. Our model predicts that the
abruptness of the switch depends upon a strong binding affinity within the Sic1-S-CDK
inhibitory complex. In vitro phosphorylation analysis using purified yeast proteins revealed
that free Clb5-Cdk1 can create positive feedback by phosphorylating Sic1 that is bound in
the inhibitory complex, and that Sic1 inhibits Clb5-Cdk1 with a sub-nanomolar inhibition
constant. Our model also predicts that if the G1-phase CDK complex is too efficient
at targeting Sic1 for destruction, then G1/S becomes a smooth and readily reversible
transition. We propose that the optimal role for the G1-phase CDK in the switch would
not be to act as a kinase activity directly responsible for abrupt degradation of CKI, but
rather to act as a priming signal that initiates a positive feedback loop driven by emerging
free S-phase CDK.
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INTRODUCTION
The major cell cycle transitions are triggered by phosphorylation
or dephosphorylation of the targets of cyclin-dependent kinases
(CDKs)(Morgan, 2007). At the transition from G1- to S-phase,
the S-phase promoting signal is generated by downregulation
of CDK inhibitors (the CKIs) that suppress the activity of the
S-phase CDK (Peter, 1997). In budding yeast, the CKI acting
at the G1/S transition, the protein Sic1, is simultaneously both
an inhibitor and a substrate of Cdk1. At the onset of S-phase
Sic1 is phosphorylated by Cdk1, thereby generating two “diphos-
phodegrons” containing two properly spaced phosphates that are
recognized by the Cdc4-SCF ubiquitin ligase (Hao et al., 2007).
Ubiquitination by Cdc4-SCF targets Sic1 for proteolysis via the
proteasome pathway (Verma et al., 1997b).
Sic1 was first identified as a substrate of Cdk1 by immunopre-
cipitation (Reed et al., 1985; Wittenberg and Reed, 1988). Later, it
was shown to be an inhibitor of Clb-Cdk1 complexes that reg-
ulates cell cycle progression at the M/G1 and G1/S transitions
(Mendenhall, 1993; Donovan et al., 1994). Transcription of SIC1
starts in late mitosis and its protein levels increase until the end
of G1 phase, followed by a rapid turnover at the G1/S transi-
tion (Schwob et al., 1994; Verma et al., 1997b). The signal for the
degradation was proposed to be the multisite phosphorylation
of Sic1 by G1-specific Cln1,2-Cdk1 complexes. This is possi-
ble because, in contrast to S- and M-phase specific Clb-Cdk1s,
Cln-Cdk1s are not inhibited by Sic1 (Verma et al., 1997a,b;
Nash et al., 2001). The destruction of Sic1 was shown to release
the Clb5,6-Cdk1 complexes required to initiate DNA replication
(Schwob and Nasmyth, 1993; Schwob et al., 1994; Schneider et al.,
1996).
Recently, we showed that the Cdk1-dependent phosphoryla-
tion of Sic1 at multiple sites occurs in a specific sequence that
forms a semi-processive phosphorylation cascade. This cascade
is mediated by Cks1, the phosphate binding adaptor subunit of
Cdk1 (Koivomagi et al., 2011a). The S-phase promoting com-
plex Clb5-Cdk1 was shown to be able to efficiently phosphorylate
all the crucial sites on Sic1 that were required for generation of
phosphodegrons. On the other hand, the G1-specific Cln2-Cdk1
complex, while still capable of phosphorylating Sic1, was much
less efficient at transferring phosphates to the critical phosphode-
gron residues at the end of the cascade. Importantly, Cln-Cdk1
complexes alone were not able to cause the degradation of Sic1
in vivo. This led us to propose that positive feedback, arising from
the emerging free Clb5,6-Cdk1 complexes, is responsible for the
degradation of Sic1, while the Cln1,2-Cdk1 complexes play an
auxiliary role as a primer of the phosphorylation cascade.
The relative effectiveness of either Clns or Clbs as the driv-
ing force of the G1/S switch depends on several factors, including
relative rates of Sic1 phosphorylation and the strength of inhi-
bition of Clb complexes by Sic1. Therefore, to understand the
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switch, it is crucial to combine quantitative biochemical analy-
sis of these parameters with a modeling approach to evaluate the
optimal parameters with respect to the dynamic qualities of the
switch. To function as a sharply defined transition point between
different cellular states, the CKI- and CDK-controlled G1/S tran-
sition should possess both ultrasensitivity and high degree of
irreversibility. An ultrasensitive signal-response filters noise by
setting a sharp threshold for switch activation and being non-
responsive to small signal fluctuations. An abrupt transition is
also important for coherence in the activation of S-phase pro-
cesses and regulatory loops (Skotheim et al., 2008). For example,
a gradual transition could create a window in which enough Cdk1
activity exists to fire some origins of replication but not enough
activity to fully inactivate all the origins and thereby prevent
genotoxic reinitiation. A high degree of irreversibility would also
ensure that transient decreases of stimulus would not reverse the
switch and interrupt processes that have already initiated.
A sharp transition threshold and irreversibility can be achieved
by creating bistability in the switching system (Novak et al.,
2007; Domingo-Sananes and Novak, 2010; Zhang et al., 2011).
Bistable switches have been described for cell cycle transitions
(Ferrell et al., 2009; Trunnell et al., 2011), and the double-negative
feedback system of the CKI/CDK module governing the G1/S
transition is a potential source of bistability. Alternatively, delayed
accumulation of multiply phosphorylated forms of Sic1 has been
proposed as a distinct mechanism to create ultrasensitivity at the
G1/S transition (Nash et al., 2001), and also for other switches
(Kim and Ferrell, 2007; Takahashi and Pryciak, 2008; Harvey
et al., 2011; Trunnell et al., 2011; Lu et al., 2012). Again, it is
not clear which of the alternative mechanisms provides the opti-
mal solution in the CKI/CDK system involving two different
cyclin-CDK complexes and a CKI.
In the present study we analyzed the optimal range and com-
binations of some of the kinetic parameters governing the G1/S
switch. Although a number of parameters may have an impact
on the switch, including protein synthesis rates, ubiquitinyla-
tion rates, proteolysis rates, and transcription factor (SBF/MBF)
activation rates, in this study we focus on the analysis of param-
eters that control the mutual counteraction of CDK and CKI.
We used a minimal model containing both G1- and S-phase
CDK complexes together with the CKI, which is an inhibitor
of the S-phase-CDK. For the model simulations we used our
experimentally validated range of inhibition and phosphorylation
parameters and realistic concentrations based on experimental
data obtained from the literature. The results provide several
important predictions about the parameter ranges that allow for
bistability of the system, as well as the realistic dynamic paths
of the G1/S switch. The conclusions based on these simulations
lay out a general framework for understanding the CDK/CKI
switches in eukaryotes.
RESULTS
Sic1 INHIBITS Clb5-Cdk1 STOICHIOMETRICALLY, WITH
SUBNANOMOLAR Ki
One of the important parameters controlling the G1/S switch is
the strength of the inhibition of Clb5/6-Cdk1 complexes by Sic1.
To quantitatively measure this inhibition we performed an in vitro
phosphorylation and inhibition assay with purified Sic1 and
cyclin-Cdk1 complexes. Figures 1A–C presents the dose-response
curves showing the effect of different concentrations of Sic1 on
the initial velocity of histone H1 phosphorylation by Cln2-Cdk1
and Clb5-Cdk1. The IC50 value for Clb5-Cdk1 was 1.7 nM, which
places Sic1 into the category of tight stoichiometric inhibitors.
As expected, the G1 complex Cln2-Cdk1 was not inhibited by
Sic1, and an effect was apparent only in the micromolar range
that corresponds to the KM value for the phosphorylation of a
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FIGURE 1 | Inhibition of Clb5-Cdk1 and Cln2-Cdk1 by Sic1. (A)
Autoradiograph of a Clb5-Cdk1 and Cln2-Cdk1 inhibition assay. Sic1 is
extensively phosphorylated by Cln2-Cdk1 whereas no detectable
phosphorylation is seen with Clb5-Cdk1. (B) Inhibition curves for
Clb5-Cdk1 and Cln2-Cdk1 are presented as the initial rates of histone H1
phosphorylation in the presence of different concentrations of Sic1. (C)
Calculated IC50 values from the experiment in panel (A). (D) The values of
IC50 change in parallel with Clb5-Cdk1concentrations when both Sic1 and
the kinase are varied in the picomolar or low nanomolar ranges.
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non-inhibitory version of Sic1 (data not shown). This suggests
that Sic1 only inhibits Cln2-Cdk1 as a competitive substrate.
The experiment presented in Figures 1A–C contained 500μM
ATP and 2.5μMHistone H1. The KM,ATP = 70μM, and the value
for KM,H1 is above 10μM (our unpublished data). Therefore, the
obtained value of IC50 is a valid estimate of the apparent inhi-
bition constant for substrate phosphorylation at saturating and
nearly physiological ATP concentration. However, the experiment
presented in Figures 1A–C was performed at low Clb5-Cdk1 lev-
els (1.5–2 nM) that are used in our standard assay conditions.
Since the estimated IC50 value was in the same concentration
range as the enzyme, the inhibition constant may prove to be even
lower. When the enzyme concentration was lowered or raised, the
IC50 value changed as well (Figure 1D). This suggests that we
can give an estimate for the apparent Ki value to be in the range
of 100 pM to 1 nM. The exact value of such a constant is diffi-
cult to determine using available methods. This extremely tight
inhibition complex should exhibit a very low off-rate, which is
an important factor in modeling the Sic1 phosphorylation and
degradation switch, as discussed below.
Sic1 IS EFFICIENTLY PHOSPHORYLATED WITHIN THE Sic1/Clb5-Cdk1
COMPLEX
The dynamics of the switch are also shaped by the rates of
Sic1 phosphorylation by Cln1,2-Cdk1 and Clb5,6-Cdk1. We
have previously shown that both Clb5-Cdk1 and Cln2-Cdk1
efficiently phosphorylate the N-terminal part of the truncated
non-inhibitory version of Sic1 (Sic1C) (Koivomagi et al.,
2011a). Substrate specificity was shown to be gained by an inter-
action between a hydrophobic docking site in Clb5 and RXL
motifs in Sic1, and in the case of Cln2-Cdk1 via a novel hydropho-
bic LLPP-docking motif in Sic1 (Koivomagi et al., 2011b; Bhaduri
and Pryciak, 2011; Koivomagi and Loog, 2011). Furthermore, by
detailed mapping of the paths of the multisite phosphorylation
cascades we found that the Clb5 specificity toward different sites,
including the pair S76/S80, which form the critical diphospho-
degrons at the end of the cascade, was much more pronounced
compared to Cln2. These observations led to the conclusion that
although Cln2-Cdk1 can phosphorylate Sic1, it cannot trigger
Sic1 degradation without the help of Clb5-Cdk1. This conclu-
sion was supported by in vivo experiments showing that, in the
absence of B-type cyclin (Clb) activity, the Clns alone were not
able to cause the degradation of Sic1. Thus, Clb-Cdk1 activity is
the driving force of Sic1 degradation at the G1/S transition. This
underscores the likely importance of a double-negative feedback
mechanism whereby Clb5-Cdk1 phosphorylates Sic1, leading to
its destruction and thereby releasing further active Clb5-Cdk1
from the inhibitory Sic1-Clb5-Cdk1 complex.
This model requires that Clb5-Cdk1 can efficiently phospho-
rylate Sic1 bound to the inhibited Clb5-Cdk1 complex. To test
this, we performed a Sic1 phosphorylation assay using partly
inhibited Clb5-Cdk1—that is, we tested the ability of Clb5
to phosphorylate a Sic1-Clb5-Cdk1 complex (Figures 2A–D).
Additionally, the phosphorylation of non-inhibitory Sic1C was
Clb5
Cln2
A B
C D
FIGURE 2 | Sic1 is efficiently phosphorylated within the
Sic1/Clb5-Cdk1 complex, when an excess of Clb5-Cdk1 is added.
Assays with Cln2-Cdk1 complexes are included for comparison. (A)
Autoradiography showing the phosphorylation of purified Sic1wt and
Sic1C by Clb5-Cdk1 and Cln2-Cdk1 complexes using 15nM Sic1 and
30nM cyclin-Cdk1 complexes. (B) The activity of Clb5-Cdk1 was
determined using 2.5μM histone H1, with and without 15 nM Sic1wt in
the assay mixture. (C,D) Quantification of the experiment presented in
panel (A). For comparison, phosphorylation rates were normalized using
cyclin-Cdk1 activity units obtained in panel (B).
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assayed in the same conditions. In these assays, 30 nM Clb5-
Cdk1 or Cln2-Cdk1 was mixed with 15 nM Sic1. To quantify the
exact fraction of uninhibited Clb5-Cdk1 activity, a control sub-
strate histone H1 was included in a separate assay (Figure 2B).
Clb5-Cdk1 phosphorylated both forms of Sic1 efficiently and at
a considerably higher rate than Cln2-Cdk1. The rate of phospho-
rylation of the full length Sic1 was similar to that of Sic1C for
both Cln2 and Clb5. These data indicate that the N-terminus of
Sic1 is freely accessible for phosphorylation when Sic1 is bound
in the inhibitory complex, and that emerging free Clb5-Cdk1,
released from the inhibitory complex as Sic1 is degraded, could
accelerate Sic1 phosphorylation and degradation, thus creating a
double-negative feedback.
We have also observed that a low level of intramolecular
Sic1 phosphorylation takes place within the inhibitory Sic1-Clb5-
Cdk1 complex during its formation (data not shown). It is par-
tially also the likely reason why the full length Sic1 showed slightly
faster phosphorylation rate compared to Sic1C (Figures 2C,D).
Indeed, structural modeling studies do not exclude the possibil-
ity that the active site of Cdk1 may be partly accessible during
the inhibitor binding (Barberis et al., 2005a,b; Barberis, 2012a,b).
The possible role of these phosphorylation events in the switch is
currently under investigation.
THE MODEL OF THE CDK/CKI-CONTROLLED G1/S SWITCH
To quantitatively analyze the impact of the inhibition strength
and the phosphorylation rates on the abruptness and the degree
of irreversibility of the G1/S switch, we constructed a mini-
mal model of Sic1 phosphorylation and degradation (Figure 3,
Table 1). As a first step, we analyzed the steady state output of
the model. This is important to understand the system in gen-
eral and to analyze the transition thresholds for the conditions
FIGURE 3 | Minimal model of the G1/S switch. Parameters used for
diagrams and simulations presented in the figures below are listed in
Tables 1 and 2. Black crosses designate the phospho-dependent
degradation of Sic1 via the SCF-proteasome pathway. Gray crosses
designate basal degradation of Sic1.
(e.g., slow growth, the arrest, or stress) when the degree of irre-
versibility of the switch may become especially important. As a
second step we analyze the behavior of the switch in the normal
dynamic circumstances of the cell cycle.
To simplify our model and avoid equation systems that lack
steady state solutions, we did not include the multisite phos-
phorylation steps, but considered the net phosphorylation and
degradation process as a single step. This was based on our
experimental data showing that accumulation of multiply phos-
phorylated species is a rapid, semi-processive process in vitro, and
that multiply phosphorylated forms of Sic1 do not accumulate
in vivo after cells are released from an α-factor arrest (Koivomagi
et al., 2011a). The latter observation suggests that Sic1 degrada-
tion is rapid compared to phosphorylation. Therefore, we can
consider the rate of phosphorylation and degradation to be a
single value that is mostly determined by phosphorylation rates.
Also, due to the negligible accumulation of multi-phosphorylated
forms of Sic1 and prompt degradation in response to increasing
Cdk1 activity in vivo, we omitted the counteracting phosphatase
from the model. This does not mean that the phosphatase does
not take part in the process but that, for simplicity, its effect
was included in the net rate constant of the whole process. The
first of the three ordinary differential equations of the model
describe free Sic1 levels, including the association and dissocia-
tion of the inhibitory complex and Cln2-dependent phosphory-
lation/degradation (Table 1). The second equation describes the
dynamics of free Clb5 concentration, which is controlled by the
Table 1 | Equations describing the minimal model of the G1/S switch.
dy1
dt
= k5 − k2y1y2 + k1y3 − k6y1 − k4y1y4
dy2
dt
= k3y2y3 − k2y1y2 + k1y3 + k6y3 + k4y3y4
dy3
dt
= k2y1y2 − k3y2y3 − k1y3 − k6y3 − k4y3y4
y1 =
[
Sic1FREE
]
y2 =
[
Clb5− Cdk1FREE
]
y3 =
[
Sic1/Clb5− Cdk1]
y4 =
[
Cln2− Cdk1] = constant at 200 nM
Conservation equations:
y2 =
[
Clb5− Cdk1TOTAL
]− y3
y1 =
[
Sic1TOTAL
]− y3
Kinetic constants (the values presented below are those used in
Figure 4. Parameter values that are varied in other figures are given in
the legends or on the figure panels):
k1 = 0.01min−1; dissociation rate of the inhibitory complex
k2 = 0.1 nM−1 ×min−1; association rate of the inhibitory complex
k3 = 0.001nM−1 ×min−1; the net rate constant for Clb5-dependent
phosphorylation and degradation of Sic1
k4 = 0.00001nM−1 ×min−1; the net rate constant for Cln2-dependent
phosphorylation and degradation of Sic1
k5 = 10nM×min−1; the basal synthesis rate of Sic1
k6 = 0.01min−1; the basal degradation rate of Sic1
The description of the system is presented in Figure 3. For the phase dia-
grams presented in Figures 5–7, the steady-state solutions for the depen-
dencies between Sic1TOTAL and Clb5-Cdk1TOTAL and Clb5-Clb5-Cdk1FREE and
Clb5-Cdk1TOTAL were derived.
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association-dissociation rates of the inhibitory complex and also
by the fast release of Clb5-Cdk1 from the inhibitory complex
upon Sic1 destruction (Verma et al., 2001). The third equation
describes the concentration changes of the inhibitory complex.
The conservation equations define the total levels of Clb5 and
Sic1. Finally, themodel includes slow basal synthesis and degrada-
tion of Sic1. This was based on the finding that although themajor
Swi5-induced transcription of SIC1 peaks at the exit frommitosis
(Schwob et al., 1994), SIC1 transcription is still observed through-
out the entire cell cycle (Knapp et al., 1996; Aerne et al., 1998).
Taken together, although considerably simplified, this minimal
model contains the basic and universal core elements of a switch
containing a double-negative feedback between a CKI and a CDK.
Additionally, the system contains a second CDK complex (the
equivalent of Cln2-Cdk1) that is not inhibited by CKI but acts
as an initiator of the switch.
The values for the phosphorylation rate constants were derived
from our experimentally determined rates of the phosphoryla-
tion of Sic1 and other specific model substrates by cyclin-Cdk1
complexes (Loog and Morgan, 2005; Koivomagi et al., 2011a,b).
A KM value of 3.3μM and a kcat value of 73min−1 were deter-
mined for Clb5-Cdk1-dependent phosphorylation for Sic1 (data
not shown). Considering that there are about six to seven phos-
phorylation steps, and only a slight phosphatase counteraction,
the net rate constant for the process of Clb5-dependent phospho-
rylation (kClb5) and degradation of Sic1 was taken to be 0.001
nM−1 × min−1. Although Cln2-Cdk1 showed only a 3–4-fold
lower rate for net phosphorylation of Sic1 in the Sic1-Clb5-Cdk1
complex (Figure 2), it was shown to have a considerably weaker
ability to phosphorylate the priming site T33, and also, to finalize
the phosphorylation cascade, thus creating a di-phosphodegron
pS76/pS80 (Koivomagi et al., 2011a). Therefore, the net rate con-
stant for Cln2-dependent phosphorylation (kCln2) was initially
taken to be 0.00001 nM−1 × min−1, two orders of magnitude
lower than the corresponding value for Clb5-Cdk1. The impor-
tance of this difference on the properties of the switch will be
further analyzed below. Note, as explained above, that these rate
constant are the net constants for both phosphorylation and
degradation.
The parameters defining the inhibitory interaction between
Sic1 and Clb5-Cdk1 were derived from the inhibition experiment
presented in Figure 1. Assuming that the diffusion-limited associ-
ation rate of an average protein–protein interaction that involves
an intrinsically disordered binding partner is in the range of 107
to 108 M−1 × min−1, then a KD of a few hundred pM would
yield a dissociation rate for the Sic1-Clb5-Cdk1 inhibitory com-
plex in the range of 10−3 to 10−2 min−1. The effect of varying
this parameter will be studied in the context of the switch. The
basal synthesis and degradation rates were taken to be relatively
slow, and for the phase diagrams below these values were chosen
to give a steady-state concentration of Sic1 of 1μM in the absence
of cyclin-Cdk1 complexes.
When the steady-state solution of this ODE system is presented
as a plot of total Clb5 levels vs. the fraction of free Clb5 at a fixed
Cln2 concentration, a steep hysteresis loop can be observed, indi-
cating that the system is a bistable switch (Figure 4A). The levels
of total Sic1 vs. total Clb5 also exhibit hysteresis (Figure 4B).
These diagrams show the two states of the switch separated by two
saddle node bifurcations. The state with high total Sic1 and low
free Clb5-Cdk1 corresponds to G1, and the state with low total
Sic1 and high levels of free Clb5-Cdk1 corresponds to S-phase. If
the cell is in G1 and the total Clb5 concentration is gradually ris-
ing, the phase paths, as shown by the arrows, reach a threshold
upon which there is a jump in free Clb5-Cdk1 steady-state value
and a drop in Sic1 levels. This is the on-switch for S-phase. This
bistable system sets a high threshold for Clb5, thereby filtering
noise, before a sharp transition that ensures an abrupt and coher-
ent start of S-phase processes. Also, the switch between the two
states is highly irreversible and resistant to transient fluctuations
in Clb5 levels. Once activated, it is hard to reverse the switch, as it
would take a several-fold drop in Clb5 concentration before Sic1
can re-accumulate to switch the system back to the G1 state.
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FIGURE 4 | Phase diagrams showing the bistability of the system at
steady state. Parameter values are provided in Table 1. The dark gray arrows
show possible paths for a gradual increase of free Clb5-Cdk1 while entering
the S-phase, and possible reversible paths (light gray arrows) in the event
of stochastic decreases in Clb5 levels. (A) Phase diagram showing the
dependence of free Clb5-Cdk1 activity on total Clb5-Cdk1 levels. When a
threshold is reached, the system switches itself into the state corresponding
to S-phase, as indicated by the upward pointing arrow. (B) Phase diagram for
the same system with the same parameter values as in panel (A), showing the
dependence of total Sic1 concentration on total Clb5-Cdk1. The threshold level
for a drop of Sic1 corresponds to the same threshold level of total Clb5-Cdk1
that triggers the jump in steady state levels of free Clb5-Cdk1 in panel (A).
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TIGHT INHIBITION OF Clb5-Cdk1 BY Sic1 AND EFFICIENT
PHOSPHORYLATION OF Sic1-Clb5-Cdk1 BY FREE Clb5-Cdk1 ARE
CRUCIAL FOR SETTING A DISCREET THRESHOLD FOR THE G1/S
TRANSITION
To understand the basic features of the switch and to determine
the optimal balance of crucial parameters that are required to
maintain the bistable nature of the system, we studied the effect of
inhibition strength and phosphorylation rates on the behavior of
the phase diagrams. In the diagrams presented in Figures 5A–D,
inhibition strength was varied by introducing different values for
the dissociation rate of the inhibitory complex. As the dissocia-
tion rate increased, the bistable behavior of the system gradually
weakened and the switch evolved to a smooth transition that can
easily slide back and forth (Figure 5D). This kind of a behavior
would potentially be very harmful for a transition like G1/S: only
a slight backward deviation of the total Clb5 levels would reverse
the cell to G1, interrupting processes like the initiation of repli-
cation, and removing the re-replication block. Thus, our model
predicts that between a Ki of 10–100 nM the on-threshold con-
tinues to decrease, and eventually the system loses its hysteresis, as
well as its switch-like response (Figures 5C,D). In this range, Sic1
becomes a readily overcome barrier for the accumulating Clb5.
Next, in the diagrams presented in Figure 6, we explored
the effect of relative phosphorylation rates. To understand the
impact of the experimentally determined strikingly weaker ability
of Cln2-Cdk1 to phosphorylate the critical output degron sites
in Sic1, compared to Clb5-Cdk1 (Koivomagi et al., 2011a), we
first varied the Cln2-dependent phosphorylation rate relative to a
fixed Clb5-dependent rate (Figures 6A–C). Importantly, steeper
hysteresis was observed when the Cln2-dependent phosphoryla-
tion rate was considerably lower compared to the rate of Clb5.
Increasing the relative Cln2-dependent rate resulted in less hys-
teresis, lowered initial Sic1 levels, and lowered the Clb5 threshold
for the transition (Figures 6A,B). Thus, the timing of the transi-
tion could potentially be tuned by Cln2 activity. However, when
Cln2 specificity toward Sic1 approaches the specificity of Clb5, the
requirement for Clb5 signal almost ceases to exist (Figure 6C).
Similarly, as in the case of a weak Ki (above), the threshold of
Total (Clb5) decreased and the discontinuity of the Clb5-Cdk1
switch was lost. Thus, both tight inhibition and cyclin specificity
are important factors for an abrupt transition and a high degree of
irreversibility. Interestingly, the effect of Cln2 specificity on bista-
bility was more pronounced compared to the effect of an increase
in Ki of the same order.
Thus, in the system described in Figure 3, where both Cln2
and Clb5 are able to send Sic1 for degradation, the signal strength
of Cln2 can potentially modulate timing by lowering the thresh-
old of Clb5 required to trigger the switch. However, our recent
results indicate that Cln2-Cdk1 cannot phosphorylate the last
phospho-degron sites in Sic1 at a sufficient rate to cause degra-
dation in vivo. On the other hand, Cln2-Cdk1 can efficiently
phosphorylate the initial residues in the Sic1 cascade, and this
primes Sic1 for efficient subsequent phosphorylation by Clb5-
Cdk1, which will finalize the cascade to send Sic1 to degradation
(Koivomagi et al., 2011a). To study how such a priming effect
could influence the switch, we gradually raised the phosphoryla-
tion rate constant for Clb5 in the absence of Cln2 activity. In this
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FIGURE 5 | (A–D) The steady state phase diagrams showing the effect of
the inhibition strength on the bistability of the G1/S switch. The dissociation
rates of the inhibitory complex were increased in 10-fold increments from
0.01 to 10min−1 as indicated. In the model, these values correspond to Ki
values of 0.1–100 nM. Arrows indicate the paths of the system at the G1/S
transition.
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FIGURE 6 | (A–C) Phase diagrams showing the effect of changes in the
relative ability of Cln2-Cdk1 to directly cause the degradation of Sic1. The
rate constant values for Cln2-Cdk1 were gradually increased as indicated.
simplified way, the different constants would roughly mimic dif-
ferent levels of Cln2 as a priming kinase (higher rate constants
being equivalent to primed Sic1). The diagrams in Figure 7 reveal
that, similarly to the scenario in Figure 6, priming by Cln2 would
influence the threshold of the switch. However, the abruptness of
the transition is not lost within a realistic range of rate constant
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FIGURE 7 | Phase diagrams showing the potential effect of
Cln2-dependent priming phosphorylation on the bistability of the
system. The rate constant value of 0.001 nM×min−1 for Clb5-Cdk1
exemplifies a system with no Cln2-dependent priming while increasing
values of this constant mimic increased levels of Cln2-dependent priming
effect. (A) Phase diagrams showing the dependence of free Clb5-Cdk1
activity on total Clb5-Cdk1 levels. (B) Phase diagrams showing the
dependence of total Sic1 concentration on total Clb5-Cdk1. The color
coding is the same for both panels.
values for Clb5-Cdk1. Such tuning of the threshold of the switch
by priming can act as a mutual control system between the
G1-CDK and S-CDK activities. If there is not enough S-phase
CDK activity, the Sic1 degradation switch is not triggered. If there
are sufficient levels of the S-phase CDK activity, but for some rea-
son the levels of G1-CDK drop, the transition would be delayed.
Thus, a priming mechanism has the advantage of connecting the
Cln and Clb signals, allowing tuning of decision-making by both
pathways. When Cln and Clb signals are independent, there is
a possibility that the switch will be triggered before sufficient
amounts of Clb5 are accumulated. In the priming model, Sic1
degradation and lifting the barrier from S-phase always requires
sufficient levels of Clb5 or other early expressed B-type cyclins.
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CYCLIN CONCENTRATIONS AND SYNTHESIS RATES
Although the phase diagrams provide a good general charac-
terization of an ODE model describing a bistable system, they
don’t necessarily fully reflect the way the system behaves in reality.
Some rates could be too slow relative to the others, in which case
steady states would not be established. In the present case, the
synthesis of Clb5 is fast, with a peak accumulation time of only
around 10–20min (Koivomagi et al., 2011b). Therefore, there
is a possibility that relatively slow phosphorylation rates or dis-
sociation rates of the inhibitory complex would not allow the
formation of the steady states described by the phase diagrams. To
address this concern, we investigated the dynamics of our model.
We numerically simulated a modified form of the ODE system
(Table 2). We searched the literature to supply realistic synthe-
sis rates and peak concentrations of the cyclins and Sic1. We
obtained experimentally estimated endogenous concentrations of
Cln1, Cln2, Cln3, Clb5, Clb6, and Sic1. The most detailed studies
have been performed by western blotting of ProtA-tagged pro-
teins and by using quantitative calibration of the blotting signals
with ProtA standards (Cross et al., 2002). Second, a study pre-
senting a global analysis of protein abundances in yeast provides
quantifications based on the western blotting of TAP-tagged pro-
teins (Ghaemmaghami et al., 2003). Using the ProtA-tag method,
the estimated average number of Sic1 molecules per diploid cell
Table 2 | Equation system used for numerical simulation of the time
courses at G1/S in Figures 8A–C, 9A–D, and 10A.
dy1
dt
= −k2y1y2 − k4y1y4 + k1y3
dy2
dt
= k8 − k2y1y2 + k3y2y3 + k4y3y4 + k1y3
dy3
dt
= k2y1(y6 − y3)− k3y2y3 − k4y3y4 − k1y3
dy4
dt
= k7
dy5
dt
= −k4y1y4 − k3y2y3 − k4y3y4
dy6
dt
= k8
y1 =
[
Sic1FREE
]
y2 =
[
Clb5− Cdk1FREE
]
y3 =
[
Sic1/Clb5− Cdk1]
y4 =
[
Cln2− Cdk1]
y5 =
[
Sic1TOTAL
]
y6 =
[
Clb5− Cdk1TOTAL
]
The kinetic constants (values presented below are those used in
Figure 8A. Parameter values for other figures are given in the legends or
on the figure panels):
k1 = 0.01min−1; dissociation rate of the inhibitory complex
k2 = 0.1 nM−1 ×min−1; association rate of the inhibitory complex
k3 = 0.001 nM−1 ×min−1; the net rate constant for Clb5-dependent
phosphorylation and degradation of Sic1
k4 = 0.00001 nM−1 ×min−1; the net rate constant for Cln2-dependent
phosphorylation and degradation of Sic1
k7 = 100nM×min−1; Cln2 synthesis rate
k8 = 30nM×min−1; Clb5 synthesis rate
The initial values for y1 (Sic1FREE ) and y5 (Sic1TOTAL) in two simulations
were 1μM.
in asynchronous cultures was reported to be 214. The study using
the TAP-tag in haploid cells provided an estimate of 768 copies of
Sic1 per cell. To calculate the realistic initial concentration value
for Sic1 for the ODE simulations, one needs to take into account
the predominantly nuclear localization of Sic1 (Huh et al., 2003).
The nuclear volume of haploid and diploid cells is thought to
be 2 and 4 fl, respectively (Cross et al., 2002). Thus, the average
estimated nuclear concentration of Sic1 in asynchronous cultures
would be 363 nM. Since Sic1 is present during only a fraction
of the cell cycle, we considered that a reasonable peak concen-
tration would be three times that of the average abundance in
asynchronous cells. Therefore, a realistic concentration of Sic1 at
its peak in G1 would be around 1μM. In fact, this value falls into
the same range as the steady state value of Sic1 in the absence of
Clb5 and Cln2 in the phase diagrams presented in Figure 7.
Analogous calculations for Clb5, whose localization is also
predominantly nuclear (Shirayama et al., 1999), give peak con-
centration of 1138 nM (115 nM for Clb6). The cyclins Cln1 and
Cln2 are localized both in cytoplasm and in nucleus (Miller and
Cross, 2000; Edgington and Futcher, 2001; Landry et al., 2012),
and therefore the cell volume for calculating their concentration
was taken to be 100 fl for the ProtA study (diploid cells) and 50 fl
for the TAP study (haploid cells). Interestingly, the obtained peak
values for Cln1 and Cln2 were about 164 and 33 nM, respectively,
which is much lower than the peak values for Clb5 and Clb6. This
fact would additionally support the model that Cln1,2 may have a
less critical role in catalyzing Sic1 degradation compared to rela-
tively abundant Clb5. Cln3 levels were recorded only by the study
using ProtA, and their concentration in G1, taking into account
the nuclear localization, was in the range of 269 nM.
Based on these calculations and the half-times of accumula-
tion of Cln2 and Clb5, the concentrations of Cln2 and Clb5 in this
model were set to rise at 30 and 100 nM per minute, respectively.
To obtain a clear and formal picture of the effect of accumulation
rates on the dynamics of the switch, a constant linear accumu-
lation was introduced (Table 2). During the short time window
of cyclin accumulation, the basal synthesis and degradation rates
of Sic1 used in the ODE system for the phase diagrams would be
too slow to significantly affect the dynamics of Sic1 degradation.
Therefore, these rates were excluded to lower the complexity of
the model.
TIGHT INHIBITION AND EFFICIENT Clb5-DEPENDENT Sic1
PHOSPHORYLATION IS IMPORTANT FOR THE ABRUPTNESS
OF THE SWITCH UNDER REALISTIC DYNAMIC CIRCUMSTANCES
The simulation of the ODE system presented in Figure 8A repre-
sents a situation with tight inhibition and high kClb5/kCln2 ratio,
analogous to the one presented in Figure 4. Although exhibit-
ing a time course with a sigmoidal shape, a fairly slow transition
from low to high Clb5-Cdk1 activity level is observed. Thus,
although the phase diagrams can provide a general description
of the system, the transitions between the alternative states may
happen less abruptly. We also investigated the effect of lowering
the kClb5/kCln2 ratio. Similarly to the conclusion made based on
the phase diagrams above, a relatively faster Cln2-dependent rate
decreased the ultrasensitivity of the signal response and slowed
the transition (Figure 8B). Also, analogously to the tendency
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FIGURE 8 | Time course simulations to analyze the abruptness of the
transition. The equation system and parameter values are provided in
Table 2. (A) The simulation with the basic set of key parameters for
inhibition and phosphorylation, similar to those used in the phase diagrams
in Figure 4. (B) The effect of faster Cln2-dependent phosphorylation rate
on the switch. The rate constant value for Cln2-Cdk1 was taken to be
equal to the “k” value of Clb5-dependent phosphorylation. (C) The effect
of weaker inhibition strength on the switch. The dissociation rate of the
inhibitory complex was raised to 10min−1, which in the model
corresponds to a Ki value of 100nM.
observed in Figure 5, increasing the Ki value in these dynamic
circumstances reduced the abruptness of the switch (Figure 8C).
If Cln2-Cdk1 was left out of the model and Clb5-Cdk1 had
its usual rate constant value of 0.001 nM−1 × min−1, the sys-
tem behaved like the one in Figure 8A (kCln2 = 0.0001 nM−1 ×
min−1), with free Clb5-Cdk1 only starting to appear when the
concentration of total Clb5 surpassed the initial concentration
of Sic1 at 1000 nM (Figure 9A). In both of these cases the start
of Sic1 degradation corresponds to the point at which Clb5
surpasses stoichiometry with Sic1. The slow Sic1 degradation pro-
file, in this case, shows that the kClb5 value of 0.001 nM−1 ×
min−1 alone would not be sufficient to cause the transition to
be abrupt. However, in such a situation S-phase would still be ini-
tiated with only a few minutes delay. This is in agreement with
our experimental observations that the mutation of the Cln1,2-
specific docking motif in Sic1 (the LLPP motif) introduced about
a 5–10min delay in Sic1 degradation after the release of the cells
from the G1 arrest (Koivomagi et al., 2011a).
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FIGURE 9 | Time course simulations showing the potential effect of
Cln2-dependent priming phosphorylation on the abruptness of the
switch. The equation system and parameter values are provided in Table 2.
(A) A system with no priming effect in the absence of Cln2. The basal rate
constant value of 0.001 nM−1 × min−1 for Clb5-Cdk1 was used. (B–D)
Different priming effects were mimicked by using the following “k” values for
Clb5-Cdk1: 0.01 nM−1 × min−1 (B), 0.03 nM−1 × min−1 (C), and 0.1 nM−1 ×
min−1 (D).
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When the effect of Cln2 was introduced in the capacity of
a primer for Clb5, it was possible to tune the threshold of
the transition (Figures 9A–C). In these simulations, different
phosphorylation constant values for Clb5 present examples of
different priming effects created by Cln2. Importantly, Cln2-
dependent priming introduced abruptness to the switch. It is
plausible that priming (phosphorylation of sites by Cln2-Cdk1
that Clb5-Cdk1 can subsequently utilize as docking sites for Cks1-
dependent finalization of the cascade) creates a mixture of Sic1
forms whose net phosphorylation rate by Clb5 is optimal to
cause a rapid decline of Sic1 levels. Indeed, lowering the num-
ber of steps in the cascade that Clb5 must pass through would
effectively raise the net rate of the Clb5-dependent process. Also,
priming of the non-Cks1-dependent slow initial step by another
kinase would lessen the burden on Clb5. Interestingly, when the
kClb5 value was raised further to 0.1 nM−1 × min−1, abrupt-
ness was retained, but the Clb5 threshold for the G1/S transition
would be about three times lower than the Clb5 peak value
(Figure 9D). This scenario would create a weak noise barrier
and would also lack the potential for a burst activation of S-
phase with the full potential of accumulating Clb5. This situation
would potentially cause genomic instability, a phenotype char-
acteristic of the SIC1 strain (Lengronne and Schwob, 2002).
Thus, the estimated range of net Clb5-dependent phosphoryla-
tion rates of 0.01 nM min−1 for the mixture of primed forms
of Sic1 is in an ideal window to achieve abruptness while main-
taining a noise-filtering threshold. It is conceivable that multisite
phosphorylation systems provide wide combinatorial flexibility
for tuning and optimization of these kinetic properties during
evolution.
We also tested the situation in which Cln2-Cdk1 alone was the
kinase responsible for degradation of Sic1, and Clb5-dependent
positive feedback was omitted (kClb5 = 0). The abruptness of
the switch was considerably reduced and the whole transition
followed a path of a slow and gradual change (Figure 10A).
This strongly suggests that the optimal mechanistic basis and the
source of the ultrasensitive signal response of the switch would be
the double-negative feedback effect of Clb5. If Cln1,2 were to act
alone, the transition would not be sufficiently abrupt and there is
no guarantee that it would not happen prematurely with insuffi-
cient Clb5 signal to promote S-phase. However, an earlier model
of Sic1 phosphorylation and degradation based the responsibility
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FIGURE 10 | Time course simulations for systems where only Cln2 is
responsible for phosphorylation and degradation of Sic1. (A) A model
similar to that in Figures 8 and 9 was used, except that the rate constant
value for Clb5-Cdk1 toward Sic1 was taken to be zero. The rate constant for
Cln2-Cdk1 was 0.001 nM−1 × min−1, which is the same value used for
Clb5-Cdk1 in Figure 8A. (B) A system that requires Cln2-dependent multisite
phosphorylation for degradation of Sic1. The sequential phosphorylation of six
sites in Sic1 was taken to be the output signal for degradation of Sic1.
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of Sic1 phosphorylation entirely on Cln2 (Nash et al., 2001; Verma
et al., 1997a). The ultrasensitive feature of the switch in this
model was later built on a theoretical presumption of equal rates
of distributive phosphorylation and the delayed accumulation
of multiply phosphorylated forms of Sic1 (Deshaies and Ferrell,
2001). To test if this scheme would improve the abruptness of
the switch, we introduced six equally Cln2-specific phosphory-
lation steps into the model, with phosphorylation at all six being
required for degradation. Clb5-dependent positive feedback effect
was excluded as in Figure 10A (for other details of this model
see Table 3). The simulation of this system did indeed create a
longer lag for the onset of the transition, but it did not improve
the abruptness of the response (Figure 10B). In reality, the path
of the transition would look even less switch-like because the N-
terminus of Sic1 contains several crucial phosphorylation sites
bearing suboptimal CDK consensus motifs and exhibits low indi-
vidual site specificity with Cln2-Cdk1 (Koivomagi et al., 2011a).
These simulations predict that although the delayed accumula-
tion of multiply phosphorylated forms could create a threshold
for Sic1 degradation, multisite phosphorylation would not add
considerably to the abruptness of the switch. This conclusion is
in agreement with the results of a theoretical analysis predict-
ing that multisite phosphorylation may provide a threshold for
a transition but is generally a poor switch (Gunawardena, 2005).
Table 3 | Equation system used for simulation of the time course for Cln2-dependent multisite phosphorylation of Sic1presented in Figure 10B.
Scheme
The kinetic constants
kon = 0.1;—the association rate of the inhibitory complex. To lower the complexity, the dissociation rate was considered very slow and not included in
this version of the model.
k1 = 0.001; k2 = 0.001; k3 = 0.001; k4 = 0.001; and k5 = 0.001;—the rate constants for Cln2-dependent phosphorylation steps.
k6 = 0.001;—the rate constant for Cln2-dependent phosphorylation of 5P-Sic1 and 5P-Sic1/Clb5-Cdk1 including the net rate for the subsequent fast
SCF-mediated degradation.
kN1 = 30; kB1 = 100; the synthesis rates of Cln2 and Clb5, respectively.
The variables
y(1); y(2); y(3); y(4); y(5); y(6);—Sic1 forms bearing 0, 1, 2, . . . , or 5 phosphates, respectively. The form with 6 phosphates was degraded by SCF and due
to the fast rate of degradation this form was not expressed as a separate variable. To lower the complexity, only a sequential 6-step process was
considered in the model.
y(7); y(8); y(9); y(10) ; y(11); y(12);—different Sic1/Clb5-Cdk1 inhibitory complexes involving Sic1 with 0, 1, 2, . . . , or 5 phosphates, respectively.
y(13); y(14); y(15);—concentrations of free Clb5-Cdk1, Cln2-Cdk1, and total Clb5-Cdk1, respectively.
The initial value for 0P-Sic1 (y(7)) was taken to be 1, the initial values for the rest of the variables were taken to be zero.
The ODE system
dy(1)/dt = −k1 × y(14) × y(1) − kon× (y(15) − y(7) − y(8) − y(9) − y(10) − y(11) − y(12))× y(1)
dy(2)/dt = k1 × y(14) × y(1) − k2 × y(14) × y(2) − kon× (y(15) − y(7) − y(8) − y(9) − y(10) − y(11) − y(12))× y(2)
dy(3)/dt = k2 × y(14) × y(2) − k3 × y(14) × y(3) − kon× (y(15) − y(7) − y(8) − y(9) − y(10) − y(11) − y(12))× y(3)
dy(4)/dt = k3 × y(14) × y(3) − k4 × y(14) × y(4) − kon× (y(15) − y(7) − y(8) − y(9) − y(10) − y(11) − y(12))× y(4)
dy(5)/dt = k4 × y(14) × y(4) − k5 × y(14) × y(5) − kon× (y(15) − y(7) − y(8) − y(9) − y(10) − y(11) − y(12))× y(5)
dy(6)/dt = k5 × y(14) × y(5) − k6 × y(14) × y(6) − kon× (y(15) − y(7) − y(8) − y(9) − y(10) − y(11) − y(12))× y(6)
dy(7)/dt = kon× (y(15) − y(7) − y(8) − y(9) − y(10) − y(11) − y(12))× y(1) − k1 × y(14) × (y(15) − y(13) − y(8) − y(9) − y(10) − y(11) − y(12))
dy(8)/dt = kon× (y(15) − y(7) − y(8) − y(9) − y(10) − y(11) − y(12))× y(2) + (k1 × y(14))× (y(15) − y(13) − y(8) − y(9) − y(10) − y(11) − y(12))− (k2 × y(14))×
(y(15) − y(13) − y(7) − y(9) − y(10) − y(11) − y(12))
dy(9)/dt = kon× (y(15) − y(7) − y(8) − y(9) − y(10) − y(11) − y(12))× y(3) + (k2 × y(14))× (y(15) − y(13) − y(7) − y(9) − y(10) − y(11) − y(12))− (k3 × y(14))×
(y(15) − y(13) − y(8) − y(7) − y(10) − y(11) − y(12))
dy(10)/dt = kon× (y(15) − y(7) − y(8) − y(9) − y(10) − y(11) − y(12))× y(4) + (k3 × y(14) × (y(15) − y(13) − y(8) − y(7) − y(10) − y(11) − y(12))− (k4 × y(14))×
(y(15) − y(13) − y(8) − y(9) − y(7) − y(11) − y(12))
dy(11)/dt = kon× (y(15) − y(7) − y(8) − y(9) − y(10) − y(11) − y(12))× y(5) + (k4 × y(14))× (y(15) − y(13) − y(8) − y(9) − y(7) − y(11) − y(12))− (k5 × y(14))×
(y(15) − y(13) − y(8) − y(9) − y(10) − y(7) − y(12))
dy(12)/dt = kon× (y(15) − y(7) − y(8) − y(9) − y(10) − y(11) − y(12))× y(6) + (k5 × y(14))× (y(15) − y(13) − y(8) − y(9) − y(10) − y(7) − y(12))− (k6 × y(14)+)×
(y(15) − y(13) − y(8) − y(9) − y(10) − y(11) − y(7))
dy(13)/dt = kB1 − kon× (y(15) − y(7) − y(8) − y(9) − y(10) − y(11) − y(12))× (y(1) + y(2) + y(3) + y(4) + y(5) + y(6))+ k6 × y(14) × y(12)
dy(14)/dt = kN1
dy(15)/dt = kB1
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DISCUSSION
The double-negative feedback model of the G1/S switch in bud-
ding yeast involves two CDK complexes and a CDK inhibitor
Sic1 that, at the same time, is the substrate of CDK. We aimed
to explore which properties such a mutual antagonism would
require to generate a useful switch. Based on mathematical mod-
eling and phosphorylation assays we found that, for the transition
to exhibit the best switch-like qualities, it is important to have
tight inhibition of Clb5-Cdk1 by Sic1 and efficient phosphory-
lation of the Sic1-Clb5-Cdk1 inhibitory complex. The low Ki
ensures that a tight and nearly stoichiometric barrier sets a
threshold for the Clb5 signal. The efficient phosphorylation and
degradation rates ensure that the double-negative feedback would
gain the momentum required to create a switch-like increase in
free Clb5-Cdk1 in response to total Clb5. We also studied the rel-
ative impact and different roles of Cln2 and Clb5 in the switch.
In this respect we analyzed several possible scenarios: first, a sce-
nario in which both Cln2 and Clb5 are capable of independently
triggering the degradation of Sic1; second, a case in which Cln2
phosphorylates Sic1 to prime further Cks1-dependent phospho-
rylation by Clb5 but is not able to cause the degradation of
Sic1 by itself; third, we modeled the situations in which either
Cln2 or Clb5 alone was responsible for phosphorylation and
degradation of Sic1; finally, we explored the impact of multisite
phosphorylation on the switch. The general conclusion derived
from these case studies was that the optimal role for Cln2-Cdk1
in the switch would not be to act as a kinase activity responsible
for abrupt degradation of CKI, but rather to act as a prim-
ing signal that triggers the feedback loop for the emerging free
Clb5-Cdk1.
Clb5-dependent positive feedback would be predicted to play
a role in Sic1 degradation at the G1/S transition, since there is
expected to be a point when the accumulating fraction of free
Clb5-Cdk1 will overcome and phosphorylate Sic1 molecules that
are bound to the inhibitory complex. This feedback is clearly
expected to have some contribution to the abruptness of the
switch. However, until recently, the extent of this effect had not
been quantitatively estimated. In addition to our recent find-
ings, Tang and colleagues used live cell fluorescent microscopy
to show that Clb5,6-dependent positive feedback promotes the
switch-like properties of the G1/S transition (Tang, pers. commu-
nication). Additionally, recent work by Barberis and colleagues
has shown the involvement of Clb5 and also later B-type cyclins
in degradation of Sic1 (Barberis et al., 2012). The authors of this
work proposed a model where a surviving fraction of Sic1 could
be involved even post-G1/S in the regulation of transcriptional
waves of later cyclin genes. In general, these findings further argue
against a solely Cln2-dependent mechanism of Sic1 degradation
and emphasize the relatively major importance of B-type cyclins
in this process.
The mutual control between Clb5 and Cln2 in tuning the
threshold point and preventing a premature G1/S transition
emphasizes the advantage of Cln2 as a primer rather than as a
qualitatively similar kinase signal relative to Clb5. In addition,
we have found that there could be other kinases besides Cln1,2
involved in priming of Sic1 for Clb5, since some phosphorylation
of anN-terminal site is seen in G1-arrested cells (Koivomagi et al.,
2011a). The inability of Cln1,2 to degrade Sic1 in vivowould likely
also be partly caused by the much lower nuclear concentration of
Cln2 compared to Clb5. Thus, it is possible that Cln1,2-Cdk1s
play only a minor role in the switch.
The initial idea that Cln1,2-Cdk1 alone could be responsible
for degradation of Sic1 was mainly based on an experiment in
which about 2-fold overexpression of the non-degradable form
of Sic1, relative to the endogenous levels of Sic1, did not inhibit
endogenous Sic1 degradation but was able to block the start of
replication (Verma et al., 1997a). However, our recent experiment
showed that about 4-fold overexpression (our unpublished quan-
tifications) of the non-degradable inhibitory domain of Sic1 fully
stabilized endogenous Sic1 (Koivomagi et al., 2011a). Thus, it
seems that at relatively low levels of the inhibitor the active Clb5-
Cdk1 is able to accumulate to the levels that exceed the threshold
capable of degrading Sic1, but not to the levels required to ini-
tiate S-phase. Another study reported that when non-degradable
Sic1 accumulates to about the same levels as endogenous wild-
type Sic1, cells are still capable of initiating DNA replication with
only a minor delay (Cross et al., 2007). It seems that if the bar-
rier set by the non-degradable inhibitor is at the same levels as
wild-type Sic1, then Clb5 will accumulate and can still trigger
S-phase. If the barrier is about 2-fold, it can degrade Sic1 but
cannot start S-phase. This raises the interesting possibility that
the Clb5-Cdk1 threshold level for initiation of Sic1 degradation
is lower than the threshold for triggering S-phase by phospho-
rylation of Sld2 and Sld3. This would ensure that the transition
always starts before the initiation of replication. Interestingly,
a similar, highly resolved substrate phosphorylation order has
been demonstrated for the accumulation of mitotic cyclin-CDK
activity in both budding yeast (Oikonomou and Cross, 2011)
and human cells (Deibler and Kirschner, 2010; Gavet and Pines,
2010).
The minimal model introduced in this study could serve
as a core system that could help to understand G1/S control
modules in other organisms. The crucial CKI at the G1/S tran-
sition in human cells, the protein p27Kip1 (Hengst et al., 1994;
Polyak et al., 1994; Toyoshima and Hunter, 1994), must be
phosphorylated by CDK to be recognized by the SCF ubiqui-
tin ligase for subsequent degradation by the proteasome pathway
(Pagano et al., 1995). It is believed that a positive feedback
effect is created by CyclinE-Cdk2-dependent phosphorylation
of the phosphodegron residue at Thr187 (Sheaff et al., 1997).
Furthermore, the phosphorylation of Thr187 is facilitated by
priming phosphorylation at Tyr88 by tyrosine kinases of the
extracellular mitogen initiated signaling pathways (Chu et al.,
2007; Grimmler et al., 2007; Jakel et al., 2012). The priming
grants CDK the access to Thr187 and partly activates the inhib-
ited CyclinE/Cdk2 by loosening the inhibitory interaction. In
fact, human tyrosine kinases, by transmitting growth factor or
cytokine signals, and Cln1,2-Cdk1 in yeast, by transmitting the
signal of the cell-size control system, both play similar roles in the
cell cycle by initiating S-phase. In both of these cases, the priming
activity is not inhibited by CKI. Thus, it is possible that the varia-
tions of the proposed priming mechanism coupled to the mutual
negative feedback of the CKI/CDK system could be function-
ally conserved across species. Therefore, the modeling approach
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presented here to estimate kinetic parameters that influence the
abruptness and irreversibility of the G1/S switch may provide
general insight into G1/S control in humans. This knowledge is
especially important since perturbations in the regulatory mod-
ule governing the G1/S is widely observed in cancer (Chu et al.,
2008).
METHODS
PROTEIN PURIFICATION
The TAP method was applied for purification of cyclin-Cdk1
complexes as described previously for Clb5-TAP-Cdk1 (Puig
et al., 2001; Ubersax et al., 2003). 3HA-Cln2-Cdk1 was puri-
fied according to published protocols (McCusker et al., 2007)
using rabbit polyclonal antibody against the haemagglutinin epi-
tope (Labas). N-terminal 6His-tagged recombinant Sic1wt and
Sic1C proteins were purified by cobalt affinity chromatogra-
phy. Cks1 was purified as described in Reynard et al. (2000).
Protein concentrations were measured by colloidal coomassie
G-250 using BSA as a standard.
KINASE ASSAYS
The general composition of the kinase assay mixture was as fol-
lows: 50mM HEPES pH 7.4, 5mM MgCl2, 150mM NaCl, 0.1%
NP-40, 20mM imidazole, 2% glycerol, 2mM EGTA, 0.2mg/ml−1
BSA, 500 nM Cks1, and 500μM ATP [with added [γ−32P]ATP
(Perkin Elmer)]. For the inhibition assay twelve reactions with
Sic1wt concentrations ranging from 10 to 0.04 nM and two reac-
tions containing no inhibitor were used. As a reference substrate,
bovine histone H1 (Upstate) with final concentration 2.5μM
was used. The concentration of kinase complex in the assay was
1.5–2 nM. Before starting the reaction enzyme-inhibitor com-
plex was formed (2min). Reaction was started by adding H1.
Two timepoints, 7 and 14min, were collected and analyzed. For
the phosphorylation assays presented in Figure 2, 15 nM Sic1wt
or Sic1C and 30 nM kinase complex were used. Four time-
points were collected: 20s, 40s, 60s, and 80s. For demonstrating
enzyme activity and Sic1 inhibition ratios 2.5 uM H1 was used as
a substrate. For data analysis GraphPad Prism 5.0 software was
used.
MODELING
The models were constructed based on mass action kinetics
using values of the kinetic constants derived from biochemi-
cal experiments. Because Sic1 concentrations in the model were
several times below the KM values for Cdk1-dependent phos-
phorylation of Sic1, velocities were expressed using kcat/KM as a
second order rate constant (v0 = kcat/KM[S][E]) instead of the
Michaelis–Menten equation. The kinetic schemes of the models
are presented in Figure 3 (for model simulations in Figures 4–7)
and Table 3 (for model simulations in Figure 10B). The time
course simulations in Figures 8, 9, and 10A were based on the
scheme in Figure 3 with the exceptions that the synthesis and
the basal degradation rates of Sic1 were omitted and linear syn-
thesis rates for Cln2 and Clb5 were added. For the steady state
diagrams we solved the equation system using MATLAB and the
steady state values for plotting the diagrams were calculated with
a step of 0.01 of the total Clb5 levels. The time course simula-
tions for Figures 4–10 were performed using the MATLAB ode45
solver.
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